Prescription Drugs
US Congress 115th Congress
Improving Access To Affordable Prescription Drugs Act [HB-1776]
Improving Access To Affordable Prescription Drugs Act This bill amends provisions of various laws relating to prescription-drug pricing and affordability. Specifically, the bill: expands reporting requirements for drug manufacturers and establishes corresponding civil penalties for noncompliance; adds reporting requirements for certain nonprofit patient-assistance programs; requires the Government Accountability Office (GAO) to report to Congress on the impact of patient-assistance programs on prescription-drug pricing and expenditures; requires
(continued...)
Sponsored by: Rep. Sean Maloney Referred To The Subcommittee On Health. on 04/05/2017
Spread the world
Gettr US Congress 115th Congress
Prescription Reduction in Costs for Everyone (PRICE) Act of 2017 [HB-1775]
Prescription Reduction in Costs for Everyone (PRICE) Act of 2017 This bill amends title XVIII (Medicare) of the Social Security Act to require the President, with respect to offering one or more Medicare-operated prescription drug plan options, to: (1) negotiate prices with drug manufacturers, and (2) establish and apply a formulary and formulary incentives. In general, a Medicare-operated drug plan must meet the same requirements as apply to other prescription drug plans. The President must report to Congress biannually on negotiations conducted
(continued...)
Sponsored by: Rep. Peter DeFazio
Referred To The Subcommittee On Health. on 04/05/2017
Spread the world
US Congress 115th Congress
Improving Access To Affordable Prescription Drugs Act [S.771]
Improving Access To Affordable Prescription Drugs Act This bill amends provisions of various laws relating to prescription-drug pricing and affordability. Specifically, the bill: expands reporting requirements for drug manufacturers and establishes corresponding civil penalties for noncompliance; adds reporting requirements for certain nonprofit patient-assistance programs; requires the Government Accountability Office (GAO) to report to Congress on the impact of patient-assistance programs on prescription-drug pricing and expenditures; requires
(continued...)
Sponsored by: Sen. Jack Reed
Read Twice And Referred To The Committee On Finance. on 03/29/2017